Metabolic liver disease in diabetes – From mechanisms to clinical trials
Bedair Dewidar(Tanta University), Michael Roden(Düsseldorf University Hospital), S. Kahl(Düsseldorf University Hospital), Kalliopi Pafili(Düsseldorf University Hospital)
Cited by 156
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k